SCHEMBL4734205

SCHEMBL4734205

O=S(=O)(NC1CCN(S(=O)(=O)c2ccccc2)CC1)c1cc2c(cc1Cl)C1(CCCCC1)c1ccc(F)cc1S2(=O)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 5/20 0.43
KMT2A Q03164 5/20 0.40
MEN1 O00255 3/20 0.40
HTT P42858 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
POLB P06746 1/20 0.38
PKM P14618 2/20 0.37
CCR3 P51677 1/20 0.37
TSHR P16473 1/20 0.37
EPHX2 P34913 1/20 0.37
XBP1 P17861 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
PKLR P30613 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4732335 0.85 SFRP1 (0.44) SFRP1KMT2AMEN1HTTPSEN1
SCHEMBL4732377 0.84 WNT3 (0.34) SFRP1KMT2AMEN1HTTPSEN1
SCHEMBL4734739 0.82 SFRP1 (0.43) SFRP1POLBEPHX2PKLRMAPT
SCHEMBL4734889 0.81 SFRP1 (0.47) SFRP1HTTPKMEPHX2PKLR
SCHEMBL4730886 0.79 MEN1 (0.36) SFRP1KMT2AMEN1POLBALDH1A1
SCHEMBL4734135 0.79 SFRP1 (0.50) SFRP1KMT2AMEN1POLBPKM
SCHEMBL4730135 0.78 PKM (0.39) KMT2AMEN1HTTPOLBPKM
SCHEMBL4730501 0.74 DPP4 (0.39) SFRP1POLBEPHX2ALDH1A1
SCHEMBL4730880 0.73 MEN1 (0.36) SFRP1KMT2AMEN1POLBALDH1A1
SCHEMBL4734751 0.73 SFRP1 (0.50) SFRP1KMT2AMEN1POLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008061029-A1 ARYL SULFONAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-05-22 WO disclosed